Security key
G7709Q104
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)
CUSIP: G7709Q104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 424,966,351
- Total 13F shares
- 357,672,122
- Share change
- +26,306,222
- Total reported value
- $13,811,713,592
- Put/Call ratio
- 60%
- Price per share
- $38.64
- Number of holders
- 537
- Value change
- +$1,029,428,030
- Number of buys
- 311
- Number of sells
- 186
Report period
Q4 2025
Institutions
537
Top holders
10
RPRX full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Royalty Pharma plc SEC filings
Royalty Pharma plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP G7709Q104
Recent filing periods:
Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Pablo G. Legorreta |
13D/G
|
Legorreta G. Pablo |
20%
|
103,112,796
|
$3,372,819,557 | $0 | 16 May 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
9.2%
from 13D/G
|
44,163,954
|
$1,558,104,371 | — | 30 Sep 2025 | |
| Capital International Investors |
13D/G
13F
|
Company |
7.7%
|
32,745,526
|
$1,265,287,125 | +$163,578,499 | 31 Dec 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
6.5%
from 13D/G
|
27,986,714
|
$987,371,261 | — | 30 Sep 2025 | |
| Severgnini Achille G. |
13D/G
|
— |
5.7%
|
24,223,082
|
$978,612,513 | -$230,404,755 | 06 Nov 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
26,200,503
|
$924,353,737 | — | 30 Sep 2025 | |
| GENERAL ATLANTIC, L.P. |
13D/G
13F
|
Company |
3.2%
|
14,243,870
|
$510,500,301 | $0 | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
2.5%
|
10,936,538
|
$385,841,061 | $0 | 30 Sep 2025 | |
| Henry A. Fernandez |
3/4/5
|
Director |
0.03%
|
123,524
|
$4,190,575 | — | 30 Jun 2025 | |
| Vlad Coric |
3/4/5
|
Director |
0%
|
10,798
|
$344,996 | — | 13 May 2025 | |
| Attached Carole Ho |
3/4/5
|
Director |
0%
|
8,558
|
$306,718 | — | 31 Jul 2025 | |
| Elizabeth H. Weatherman |
3/4/5
|
Director |
0%
|
8,558
|
$306,718 | — | 31 Jul 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
4.1%
|
17,372,502
|
$612,901,870 | — | 30 Sep 2025 | |
| Swedbank AB |
13F
|
Company |
2.9%
|
12,200,270
|
$430,425,526 | — | 30 Sep 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.8%
|
11,965,633
|
$422,147,532 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
10,272,753
|
$362,422,726 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
7,617,413
|
$268,026,898 | — | 30 Sep 2025 | |
| Caledonia (Private) Investments Pty Ltd |
13F
|
Company |
1.8%
|
7,547,609
|
$266,279,646 | — | 30 Sep 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
4,657,407
|
$164,313,319 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.96%
|
4,075,239
|
$143,774,431 | — | 30 Sep 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.77%
|
3,282,174
|
$115,795,099 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.74%
|
3,151,660
|
$111,190,565 | — | 30 Sep 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.74%
|
3,129,936
|
$110,424,143 | — | 30 Sep 2025 | |
| Patient Capital Management, LLC |
13F
|
Company |
0.73%
|
3,117,850
|
$109,997,741 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.71%
|
3,025,712
|
$106,747,119 | — | 30 Sep 2025 | |
| NEW SOUTH CAPITAL MANAGEMENT INC |
13F
|
Company |
0.69%
|
2,918,263
|
$102,956,319 | — | 30 Sep 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.66%
|
2,822,566
|
$99,580,130 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.62%
|
2,646,772
|
$93,378,104 | — | 30 Sep 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.58%
|
2,481,771
|
$87,556,881 | — | 30 Sep 2025 | |
| Dorsey Asset Management, LLC |
13F
|
Company |
0.55%
|
2,350,449
|
$82,923,841 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.53%
|
2,235,133
|
$78,855,492 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.49%
|
2,100,490
|
$74,104,248 | — | 30 Sep 2025 | |
| Amundi |
13F
|
Individual |
0.49%
|
2,069,985
|
$74,788,558 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.46%
|
1,961,086
|
$69,187,107 | — | 30 Sep 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.46%
|
1,936,448
|
$68,317,886 | — | 30 Sep 2025 | |
| HOMESTEAD ADVISERS CORP |
13F
|
Company |
0.45%
|
1,902,440
|
$67,118,083 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.41%
|
1,759,620
|
$62,079,425 | — | 30 Sep 2025 | |
| Clark Capital Management Group, Inc. |
13F
|
Company |
0.41%
|
1,751,842
|
$61,804,984 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
1,645,627
|
$58,057,721 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.37%
|
1,589,516
|
$56,078,128 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
1,541,598
|
$54,387,578 | — | 30 Sep 2025 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.36%
|
1,518,699
|
$53,579,701 | — | 30 Sep 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.36%
|
1,516,321
|
$53,495,805 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.35%
|
1,483,676
|
$52,344,089 | — | 30 Sep 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.34%
|
1,450,703
|
$51,180,768 | — | 30 Sep 2025 | |
| Regal Partners Ltd |
13F
|
Company |
0.34%
|
1,435,126
|
$50,631,245 | — | 30 Sep 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.33%
|
1,405,913
|
$49,596,595 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
1,271,642
|
$44,863,541 | — | 30 Sep 2025 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
0.29%
|
1,248,619
|
$44,051,279 | — | 30 Sep 2025 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.29%
|
1,224,118
|
$43,186,883 | — | 30 Sep 2025 |
Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q4 2025
As of 31 Dec 2025,
Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by
537 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
357,672,122 shares.
The largest 10 holders included
MORGAN STANLEY, Capital International Investors, FMR LLC, BlackRock, Inc., BAILLIE GIFFORD & CO, Swedbank AB, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, VANGUARD GROUP INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
537
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
484
Q4 2025 holders
537
Holder diff
53
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.